Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

4774 - Association of the rs4567312 variant in the leptin receptor gene with plasma leptin concentrations and lung cancer incidence in the PREDIMED study


11 Sep 2017


Poster display session


Cancer Prevention;  Translational Research;  Thoracic Malignancies


Judith Begona Ramirez Sabio


Annals of Oncology (2017) 28 (suppl_5): v1-v21. 10.1093/annonc/mdx361


J.B. Ramirez Sabio1, J.V. Sorlí2, C. Ortega-Azorín2, P. Carrasco2, E.M. Asensio2, R. Barragán2, R. Fernández-Carrión2, C. Gallego2, J.I. González-Arráez2, J.A. Perez Fidalgo3, Ó. Coltell4, D. Corella2

Author affiliations

  • 1 Medical Oncology Unit, Hospital de Sagunt, 46520 - Pto. Sagunto/ES
  • 2 Preventive Medicine And Ciber Fisiopatología De La Obesidad Y Nutrición, University of Valencia, 46010 - Valencia/ES
  • 3 Medical Oncology, Hospital Clinico Universitario de Valencia, 46010 - Valencia/ES
  • 4 Computer Languages And Systems. School Of Technology And Experimental Sciences, Jaume I University, Castellón/ES


Abstract 4774


Many studies have found leptin related genes involved in tumorigenesis and have suggested it may play a role in the pathogenesis of lung cancer. Leptin Receptor (LEPR) is expressed in many tissues and cells, including lung mucosal cells. LEPR was reported to be associated with tumor cell proliferation and angiogenesis. Our objective has been to estimate the association between the rs4567312-LEPR gene and lung cancer incidence in a Mediterranean population.


We analyzed 1094 participants (398 men, 696 women) recruited in the PREDIMED-Valencia Study. Participants were high cardiovascular risk subjects aged 67±6 years at baseline. PREDIMED is a multicenter randomized, controlled trial aimed at assessing the effect of the Mediterranean diet (MedDiet) on cardiovascular prevention (primary outcome). Cancer incidence was a secondary outcome in this trial. Demographic, clinical, life-style, biochemical, and genetic variables were obtained. Subjects were followed-up prospectively from 2003 to 2014 (in the extended-follow-up).


We detected 12 new cases of lung cancer from 2003 to 2014 (1.1% cumulative incidence). Tobacco smoking was strongly associated with lung cancer incidence (91.7% of current or former smokers in lung cancer subjects vs 41.5% in the non-cancer participants (p = 0.001). In the whole population, prevalence of the rs4567312 polymorphism was: 95.5% CC, 4.4% CT and 0.1% TT. We also detected in the whole population an association between this polymorphism and plasma leptin concentrations, 26.9±22.9 ng/mL in CC vs 18.4±16.7 ng/mL in T carriers (p = 0.013). We found a strong association between the rs4567312-LEPR polymorphism and lung cancer risk, being higher in carriers of the T-allele. This association remained statistically significant (OR = 7.61; 95% CI: 1.74-33.37 for T-carriers vs CC) even after adjustment for gender, age, tobacco smoking, dietary intervention group (MedDiet vs control diet) and leptin levels.


T-carriers allele in the rs4567312-LEPR polymorphism presented a higher incidence of lung cancer in this Mediterranean population even after adjustment for tobacco smoking and dietary intervention.

Clinical trial identification

Controlled-trials.com number ISRCTN35739639

Legal entity responsible for the study

Instituto de Salud Carlos III and University of Valencia


Instituto de Salud Carlos III


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.